Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jan:Chapter 12:12.11.1-12.11.17.
doi: 10.1002/0471142735.im1211s64.

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays

Affiliations

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays

David C Montefiori. Curr Protoc Immunol. 2005 Jan.

Abstract

Neutralizing antibody assays are powerful tools for assessing humoral immunity in AIDS virus infection and vaccine development. Although many different assays have been described, all are based on the same principle, measuring reductions in virus infectivity. This unit describes two assays utilizing a genetically engineered cell lines that are susceptible to infection by most strains of HIV-1, SIV, and SHIV. One assay is designed for optimal performance with uncloned viruses produced in either PBMC or CD4+ T cell lines. A second assay is designed for single-cycle infection with molecularly cloned pseudoviruses produced by transfection in 293T cells. Both assays are performed in a 96-well format and use tat-responsive luciferase reporter gene expression as readout.

PubMed Disclaimer

Similar articles

Cited by

References

Literature Cited

    1. Berger, E.A., Murphy, P.M., and Farber, J.M. 1999. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
    1. Brandt, S.M., Mariani, R., Holland, A.U., Hope, T.J., and Landau, N.R. 2002. Association of chemokine-mediated block to HIV entry with coreceptor internalization. J. Biol. Chem. 277:17921-19299.
    1. Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K., Tartaglia, J., Caudrelier, P., Habib, R.E.L., Klein, M., Lazzarin, A., Stablein, D., Deers, M., Corey, L., Greenberg, M.L., Schwartz, D.H., and Montefiori, D.C. 2000. Immunization with recombinant canarypox vectors expressing membrane-anchored gp120 followed by gp160 protein boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 16:2019-2035.
    1. Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N., Gerard, N., Gerard, C., and Sodroski, J. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
    1. Hanson, C.V., Crawford-Miksza, L., and Sheppard, H.W. 1990. Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers. J. Clin. Microbiol. 28:2030-2034.

LinkOut - more resources